Celularity Insider Trades
NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Celularity insider activity
Over the last 12 months, Celularity insiders reported 25 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Hariri Robert J (Chief Executive Officer) reporting a transaction in 3,281 shares on Apr 13, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CELU's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CELU insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 13, 2026 | Brigido StephenPres., Functional Regeneration | Tax withholding | 268 | $343.04 | Form 4 |
| Apr 13, 2026 | Brigido StephenPres., Functional Regeneration | Option exercise | 821 | — | Form 4 |
| Apr 13, 2026 | Haines John RSenior Exec Vice President | Tax withholding | 583 | $746.24 | Form 4 |
| Apr 13, 2026 | Haines John RSenior Exec Vice President | Option exercise | 1,641 | — | Form 4 |
| Apr 13, 2026 | Hariri Robert JChief Executive Officer | Tax withholding | 1,182 | $1.51K | Form 4 |
| Apr 13, 2026 | Hariri Robert JChief Executive Officer | Option exercise | 3,281 | — | Form 4 |
| Jan 12, 2026 | Parks Diane L.Director | Award | 30,000 | — | Form 4 |
| Jan 12, 2026 | LeVien VincentDirector | Award | 28,847 | — | Form 4 |
| Jan 12, 2026 | Diamandis PeterDirector | Award | 20,385 | — | Form 4 |
| Jan 12, 2026 | Ling Geoffrey M.D.Director | Award | 19,231 | — | Form 4 |
| Jan 12, 2026 | LeVien VincentDirector | Award | 28,847 | — | Form 4 |
| Jan 12, 2026 | Diamandis PeterDirector | Award | 20,385 | — | Form 4 |
| Jan 12, 2026 | Parks Diane L.Director | Award | 30,000 | — | Form 4 |
| Jan 12, 2026 | Ling Geoffrey M.D.Director | Award | 19,231 | — | Form 4 |
| Dec 29, 2025 | Diamandis PeterDirector | Award | 125,000 | — | Form 4 |
| Dec 29, 2025 | Ling Geoffrey M.D.Director | Award | 125,000 | — | Form 4 |
| Dec 29, 2025 | Parks Diane L.Director | Award | 125,000 | — | Form 4 |
| Dec 29, 2025 | LeVien VincentDirector | Award | 125,000 | — | Form 4 |
| Dec 19, 2025 | Diamandis PeterDirector | Award | 67,416 | — | Form 4 |
| Dec 19, 2025 | Parks Diane L.Director | Award | 67,416 | — | Form 4 |
| Dec 19, 2025 | Ling Geoffrey M.D.Director | Award | 67,416 | — | Form 4 |
| Nov 19, 2025 | Diamandis PeterDirector | Award | 47,042 | — | Form 4 |
| Nov 19, 2025 | Ling Geoffrey M.D.Director | Award | 44,379 | — | Form 4 |
| Nov 19, 2025 | LeVien VincentDirector | Award | 3,699 | — | Form 4 |
| Nov 19, 2025 | Parks Diane L.Director | Award | 61,539 | — | Form 4 |
| Apr 13, 2025 | Hariri Robert JChief Executive Officer | Tax withholding | 1,154 | $1.89K | Form 4 |
| Apr 13, 2025 | Hariri Robert JChief Executive Officer | Option exercise | 3,281 | — | Form 4 |
| Apr 13, 2025 | Brigido StephenPres., Functional Regeneration | Tax withholding | 268 | $439.52 | Form 4 |
| Apr 13, 2025 | Brigido StephenPres., Functional Regeneration | Option exercise | 820 | — | Form 4 |
| Apr 13, 2025 | Beers David CChief Financial Officer | Tax withholding | 360 | $590.40 | Form 4 |
| Apr 13, 2025 | Beers David CChief Financial Officer | Option exercise | 1,025 | — | Form 4 |
| Apr 13, 2025 | Haines John RSenior Exec Vice President | Tax withholding | 577 | $946.28 | Form 4 |
| Apr 13, 2025 | Haines John RSenior Exec Vice President | Option exercise | 1,641 | — | Form 4 |
| Apr 13, 2025 | Hariri Robert JChief Executive Officer | Tax withholding | 1,154 | $1.89K | Form 4 |
| Apr 13, 2025 | Hariri Robert JChief Executive Officer | Option exercise | 3,281 | — | Form 4 |
| Feb 17, 2025 | Haines John RSenior Exec Vice President | Tax withholding | 7,035 | $15.05K | Form 4 |
| Feb 17, 2025 | Haines John RSenior Exec Vice President | Option exercise | 20,000 | — | Form 4 |
| Feb 17, 2025 | Beers David CChief Financial Officer | Tax withholding | 4,396 | $9.41K | Form 4 |
| Feb 17, 2025 | Beers David CChief Financial Officer | Option exercise | 12,500 | — | Form 4 |
| Feb 17, 2025 | Brigido StephenPres., Functional Regeneration | Tax withholding | 3,272 | $7.00K | Form 4 |
| Feb 17, 2025 | Brigido StephenPres., Functional Regeneration | Option exercise | 10,000 | — | Form 4 |
| Jan 24, 2025 | Lim Kok Thay & Dragasac Ltd & Genting Berhad10% Owner | Option exercise | 652,981 | $1.35M | Form 4 |
| Jan 24, 2025 | Lim Kok Thay & Dragasac Ltd & Genting Berhad10% Owner | Option exercise | 535,274 | $1.11M | Form 4 |
| Dec 19, 2024 | Diamandis PeterDirector | Award | 67,416 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4